
Catalyst for a Cure 2018 Research Progress Report
Biomarkers can provide physicians with better tools to diagnose and manage glaucoma before vision is lost, as well as accelerate better treatments for glaucoma. …
Biomarkers can provide physicians with better tools to diagnose and manage glaucoma before vision is lost, as well as accelerate better treatments for glaucoma. …
We talked with Dr. Janey Wiggs, a scientific advisor for Glaucoma Research Foundation, at the AAO 2017 meeting in New Orleans about what’s new in genetic research for treating glaucoma.
Andrew Huberman, PhD is a principal investigator in the Catalyst for a Cure Biomarkers Team funded by Glaucoma Research Foundation in San Francisco, CA. …
The Srinivasan Laboratory at the University of California, Davis, develops novel optical imaging techniques and diagnostics with applications spanning from basic to clinical research.
Dr. Goldberg’s glaucoma research is directed at neuroprotection and regeneration of retinal ganglion cells and other retinal neurons.
Retinal ganglion cells (RGCs) are particularly important in glaucoma because they are the cells that are damaged by the disease.
“We’re not just trying to achieve some answer in terms of scientific curiosity, but our aim is to really help people who are suffering from this disease.” — Alfredo Dubra, PhD …
Vision scientists have discovered that naturally occurring molecules known as lipid mediators have the potential to halt the progression of glaucoma.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
FOR EYECARE PROFESSIONALS
FOR EYECARE PROFESSIONALS
Glaucoma Research Foundation • 251 Post Street, Suite 600 • San Francisco, CA 94108 • 415-986-3162
Send us an email
We are a 501c3 tax-exempt national nonprofit. Our tax ID number is 94-2495035. Our EIN number is 94-2495035.
Copyright 2023 all rights reserved.
Print Subscription
We will mail Gleams anywhere in the United States and Canada, but we do not mail internationally. Please sign up for the email edition if you live outside of the US or Canada.
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.
E-mail Subscription
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.